Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Mar 31:7:43-52.
doi: 10.2147/OAJC.S85565. eCollection 2016.

Unscheduled bleeding and contraceptive choice: increasing satisfaction and continuation rates

Affiliations
Review

Unscheduled bleeding and contraceptive choice: increasing satisfaction and continuation rates

Jennifer Villavicencio et al. Open Access J Contracept. .

Abstract

Approximately half (51%) of the 6.6 million pregnancies in the US each year are unintended and half of those pregnancies (54%) occur among women not using contraception. Many women discontinue their contraceptives due to method dissatisfaction. Bothersome unscheduled bleeding is one of the main reasons cited by women for stopping a birth control method. Improving counseling and management of these side effects will aide in increasing satisfaction with contraceptive methods. The following review will discuss the bleeding profiles associated with the contraceptive options available in the US. A valuable resource from the Centers for Disease Control and Prevention, the US Selected Practice Recommendations for Contraceptive Use, will be introduced. Definitions of the types of unscheduled bleeding are included, as well as strategies for treatment for each contraceptive method. The evidence whether or not anticipatory counseling increases continuation rates will also be reviewed.

Keywords: contraception; drug treatment; patient satisfaction; unscheduled uterine bleeding.

PubMed Disclaimer

Conflict of interest statement

Disclosure Dr Jennifer Villavicencio has no conflicts of interest to disclose. Dr Rebecca H Allen is a Nexplanon trainer for Merck, a Liletta trainer for Actavis, and has consulted for Bayer on IUDs.

Figures

Figure 1
Figure 1
Management of women with bleeding irregularities while using contraception. Notes: #If clinically warranted, evaluate for underlying condition. Treat the condition or refer for care. *Not recommended during first 21 days of extended or continuous pill or ring use; not recommended more than once per month because contraceptive effectiveness may be reduced. Adapted from: cdc.gov [homepage on the Internet]. U.S. Selected Practice Recommendations for Contraceptive Use, 2013: Centers for Disease Control and Prevention; 2013. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6205a1.htm. Accessed February 5, 2016. Abbreviations: Cu-IUD, copper intrauterine device; LNG, levonorgestrel; DMPA, depot medroxyprogesterone acetate; CHC, combined hormonal contraceptive; NSAIDs, non-steroidal anti-inflammatory drugs.

Similar articles

  • Strategies to improve adherence and continuation of shorter-term hormonal methods of contraception.
    Mack N, Crawford TJ, Guise JM, Chen M, Grey TW, Feldblum PJ, Stockton LL, Gallo MF. Mack N, et al. Cochrane Database Syst Rev. 2019 Apr 23;4(4):CD004317. doi: 10.1002/14651858.CD004317.pub5. Cochrane Database Syst Rev. 2019. PMID: 31013349 Free PMC article.
  • Canadian Contraception Consensus (Part 2 of 4).
    Black A, Guilbert E; Co-Authors; Costescu D, Dunn S, Fisher W, Kives S, Mirosh M, Norman WV, Pymar H, Reid R, Roy G, Varto H, Waddington A, Wagner MS, Whelan AM; Special Contributors; Ferguson C, Fortin C, Kielly M, Mansouri S, Todd N. Black A, et al. J Obstet Gynaecol Can. 2015 Nov;37(11):1033-9. doi: 10.1016/s1701-2163(16)30054-8. J Obstet Gynaecol Can. 2015. PMID: 26629725 English, French.
  • Canadian Contraception Consensus (Part 1 of 4).
    Black A, Guilbert E; Co-Authors; Costescu D, Dunn S, Fisher W, Kives S, Mirosh M, Norman WV, Pymar H, Reid R, Roy G, Varto H, Waddington A, Wagner MS, Whelan AM; Special Contributors; Ferguson C, Fortin C, Kielly M, Mansouri S, Todd N; Society of Obstetricians and Gynaecologists of Canada. Black A, et al. J Obstet Gynaecol Can. 2015 Oct;37(10):936-42. doi: 10.1016/s1701-2163(16)30033-0. J Obstet Gynaecol Can. 2015. PMID: 26606712 English, French.
  • Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception.
    Black A, Guilbert E, Costescu D, Dunn S, Fisher W, Kives S, Mirosh M, Norman W, Pymar H, Reid R, Roy G, Varto H, Waddington A, Wagner MS, Whelan AM, Mansouri S. Black A, et al. J Obstet Gynaecol Can. 2016 Feb;38(2):182-222. doi: 10.1016/j.jogc.2015.12.002. Epub 2016 Feb 26. J Obstet Gynaecol Can. 2016. PMID: 27032746 English, French.
  • Managing menstrual disturbances.
    Barnett B. Barnett B. Netw Res Triangle Park N C. 1995 Jun;15(4):8. Netw Res Triangle Park N C. 1995. PMID: 12289833

Cited by

References

    1. cdc.gov [homepage on the Internet] U.S. Selected Practice Recommendations for Contraceptive Use, 2013: Adapted from the World Health Organization Selected Practice Recommendations for Contraceptive Use. 2nd Edition. Centers for Disease Control and Prevention; 2013. [Accessed February 5, 2016]. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6205a1.htm.
    1. Inoue K, Barratt A, Richters J. Does research into contraceptive method discontinuation address women’s own reasons? A critical review. J Fam Plann Reprod Health Care. 2015;41(4):292–299. - PubMed
    1. Westhoff CL, Heartwell S, Edwards S, et al. Oral contraceptive discontinuation: do side effects matter? Am J Obstet Gynecol. 2007;196(4):412.e1–e6. - PMC - PubMed
    1. Moreau C, Cleland K, Trussell J. Contraceptive discontinuation attributed to method dissatisfaction in the United States. Contraception. 2007;76(4):267–272. - PubMed
    1. Grunloh DS, Casner T, Secura GM, Peipert JF, Madden T. Characteristics associated with discontinuation of long-acting reversible contraception within the first 6 months of use. Obstet Gynecol. 2013;122(6):1214–1221. - PMC - PubMed

LinkOut - more resources